FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Azithromycin (Azasite) Ophthalmic Solution 1%
Status: Currently in Shortage
»Date first posted: 02/22/2022
»Therapeutic Categories: Ophthalmology

Akorn Pharmaceuticals (New 02/22/2022)

Company Contact Information:

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Azasite (Azithromycin Ophthalmic Solution) 1% (NDC 17478-307-03), 2.5mL On backorder. Estimated Availability May/June 2022 Other

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English